NewGenIvf Group Limited - Class A Ordinary Shares (NIVF)
0.5310
-0.1540 (-22.48%)
NASDAQ· Last Trade: Jun 5th, 12:57 PM EDT
Detailed Quote
Previous Close
0.6850
Open
0.5729
Bid
0.5310
Ask
0.5311
Day's Range
0.5308 - 0.6199
52 Week Range
0.6440 - 1,067.58
Volume
20,556,976
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
5,221,887
Chart
About NewGenIvf Group Limited - Class A Ordinary Shares (NIVF)
NewGenIvf Group Limited is a biotechnology company focused on providing innovative solutions and services in the field of reproductive health and fertility. The company specializes in advanced in vitro fertilization (IVF) technologies and offers a range of services to assist individuals and couples in their journey to conceive. Through its state-of-the-art laboratories and clinical expertise, NewGenIvf Group is dedicated to improving patient outcomes and enhancing the overall experience of assisted reproduction, while also engaging in research and development to advance fertility treatments. Read More
NewGen's 6% Stake in K25.ai Now Valued at US$6 MillionCompany will Leverage Expertise of K25.ai’s Andy Cheung to Develop Digital Asset Treasury Strategy
BANGKOK, May 28, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has executed a Share Purchase Agreement and an Exclusive Agency Agreement with K25.ai, an APAC-focused AI-powered live-streaming and watch-to-predict platform led by technology veteran Andy Cheung.
Sphere 3D Corp. (NASDAQ: ANY) has received a critical approval advancing the company into the final stages of its proposed merger ahead of the anticipated June 1, 2026 closing date, positioning the combined entity as an emerging AI infrastructure, data center, and digital power platform.
NewGenIvf Group Limited (NASDAQ: NIVF) stock faces downward pressure on Friday as retail traders engage in profit-taking following a massive 50% AI-driven rally.
Initial US$2 million strategic investment values K25.ai at US$100 million pre-money, with option to invest up to US$10 million if exercised in full; exclusive APAC agency partnership provides NewGenIVF with exposure to AI-assisted prediction markets, live-streaming engagement and creator-led information markets across permitted APAC markets
BANGKOK, April 01, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the “SEC”).
BANGKOK, March 02, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has entered into a Memorandum of Understanding (“MOU”) with Women in Web3 Hong Kong Limited (“WiW3”), a leading community organization dedicated to advancing women and their allies in Hong Kong’s Web3 ecosystem. Under the MOU, NewGen and WiW3 intend to collaborate on a co-branded public awareness and education campaign anchored by the NewGen manifesto and petition, with a primary focus on women's health literacy.
BANGKOK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (“NewGen” or the “Company,” NASDAQ: NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced the appointment of award-winning Web3 legal and regulatory specialist Joshua Chu as Senior Counsel to lead the Group’s tokenization strategy, alongside the formal engagement of Evident Capital, Hong Kong’s first fully integrated, SFC-licensed tokenization and alternative assets platform, to support the launch of NIVF’s inaugural tokenized bond issuance of up to USD 30 million targeted for completion by the first quarter of 2026.
